1. Home
  2. POCI vs LITS Comparison

POCI vs LITS Comparison

Compare POCI & LITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision Optics Corporation Inc.

POCI

Precision Optics Corporation Inc.

HOLD

Current Price

$4.25

Market Cap

34.7M

Sector

Health Care

ML Signal

HOLD

LITS

Lite Strategy Inc.

N/A

Current Price

$1.13

Market Cap

41.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
POCI
LITS
Founded
1982
2000
Country
United States
United States
Employees
N/A
4
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.7M
41.5M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
POCI
LITS
Price
$4.25
$1.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
33.4K
218.6K
Earning Date
05-14-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$19,091,269.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.55
$0.95
52 Week High
$6.04
$3.03

Technical Indicators

Market Signals
Indicator
POCI
LITS
Relative Strength Index (RSI) 49.15 44.15
Support Level $3.96 $1.01
Resistance Level $4.83 $1.16
Average True Range (ATR) 0.27 0.05
MACD -0.00 -0.00
Stochastic Oscillator 33.82 8.37

Price Performance

Historical Comparison
POCI
LITS

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

About LITS Lite Strategy Inc.

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.

Share on Social Networks: